(c) 2024 PillSync.com

ranolazine tablet film coated extended release

1 INDICATIONS AND USAGE Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 ) Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

lupin pharmaceuticals, inc.


5 years ago OVAL YELLOW LU L32 ranolazine tablet film coated extended release

OVAL YELLOW LU L32

5 years ago OVAL YELLOW LU L32 ranolazine tablet film coated extended release

LU L32 OVAL YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING

RANOLAZINE extended-release tablets are supplied as film-coated, oval-shaped, extended-release tablets in the following strengths: 500 mg tablets are orange, debossed with "L31" on one side and "LU" on other side 1000 mg tablets are yellow, debossed with "L32" on one side and "LU" on other side

RANOLAZINE extended-release tablets are available in: Strength NDC Code Bottles of 60 500 mg 68180-354-07 Bottles of 500 500 mg 68180-354-02 Bottles of 60 1000 mg 68180-355-07 Bottles of 500 1000 mg 68180-355-02 Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].


More pills like OVAL LU L32

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site